Delaware Supreme Court rules on AIM Immunotech bylaw challenge; election unchanged

AIM ImmunoTech Inc.

Delaware Supreme Court affirmed in part, reversed Court of Chancery post-trial decision in Kellner v. AIM Immunotech.
Court found one bylaw facially invalid and others unenforceable, but no remedy because Kellner's conduct was deemed deceptive.
Results of 2023 Annual Meeting (director election) remain unchanged as reported on Jan 10, 2024.
Company reviewing opinion and will amend its bylaws to comply with rulings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.